Orexigen Therapeutics, Inc. recalls Contrave (naltrexone HCl and bupropion HCl) Extended-Release Tablets, 8 mg/90 mg, 120-count bottle, Rx only, Distributed
Recalled August 22, 2018 · FDA recall D-1099-2018 · Orexigen Therapeutics
Hazard
Defective Container: Customer complaints of punctures in the bottle. · FDA Class III
Units
95,296 bottles
Sold at
Nationwide in the USA
Description
Defective Container: Customer complaints of punctures in the bottle.
Product
Contrave (naltrexone HCl and bupropion HCl) Extended-Release Tablets, 8 mg/90 mg, 120-count bottle, Rx only, Distributed by Orexigen therapeutics, Inc., La Jolla, CA 92037, NDC 51267-890-99.
Manufacturer(s)
Orexigen Therapeutics, Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →